The PCT service platform helps cell therapy developers with their clinical manufacturing challenges. From start to finish, we help clients develop and advance their therapeutics with commercialization in mind. Leveraging our cell therapy-focused experience, we help clients improve their cost-effectiveness, regulatory compliance, and time-to-market.
Our service approach to clinical manufacturing begins with a strategic approach to technology transfers. Our team of experts has rapidly executed high profile successful technology transfers.
We understand the challenges inherent to patient-specific cell therapy logistics. The cost of idle capacity for cell therapies can be enormous—driving up the total cost of goods (COG) for a therapy. Handling clinical manufacturing through us helps cell therapies minimize the impact of scheduling limitations on their COG. To ensure rapid deployment of cell therapies upon completion, our logistics network includes relationships with a specialty air carrier fleet with more than 130 aircraft serving 100+ cities nationwide.
We have years of experience in creating a secure supply chain for cGMP-compliant cell therapy manufacturing. Our robust procurement sources, warehousing options, and materials controls help clients keep costs down while minimizing
We use a Development by Design (
The PCT service p
We have years of experience in helping cell therapy developers from all backgrounds with their technical and engineering challenges. Technical services, such as technology transfers, are handled by an experienced team that has dozens of successful transfers to their credit.
We can provide outsourced manufacturing for cell therapies and
This includes services such as Laboratory Information Management Systems (LIMS), Manufacturing Execution Systems (MES), Document Management Systems (DMS) and more—all to help you track, manage, and execute your cell therapy development and manufacturing as efficiently as possible.